aluates Reports

$ 0.0

Automative

Global Depression Medicine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-6E6168

Global Depression Medicine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Depression Medicine Market Research Report 2025

Code: QYRE-Auto-6E6168

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Astrazeneca plc

Eli Lilly and Company

Novartis

GlaxoSmithKline PLC

Otsuka Pharmaceutical

Abbott Laboratories

Gedeon Richter

Janssen Pharmaceuticals

Lupin Pharmaceuticals

Luye Pharma

MSI Methylation Sciences

Naurex

SK Biopharmaceuticals

Depression Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Depression Medicine Market

The global market for Depression Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Depression Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Medicine.

The Depression Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Depression Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Depression Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Depression Medicine Market Report

Report Metric	Details
Report Name	Depression Medicine Market
CAGR	5%
Segment by Type	Tricyclic Antidepressants Serotonin-norepinephrine Inhibitors Atypical Antipsychotics Selective Serotonin Reuptake Inhibitors Benzodiazepines Tetracyclic Antidepressants Monoamine Oxidase Inhibitors Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter, Janssen Pharmaceuticals, Lupin Pharmaceuticals, Luye Pharma, MSI Methylation Sciences, Naurex, SK Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Depression Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Depression Medicine Market report?

Ans: The main players in the Depression Medicine Market are Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter, Janssen Pharmaceuticals, Lupin Pharmaceuticals, Luye Pharma, MSI Methylation Sciences, Naurex, SK Biopharmaceuticals

What are the Application segmentation covered in the Depression Medicine Market report?

Ans: The Applications covered in the Depression Medicine Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Depression Medicine Market report?

Ans: The Types covered in the Depression Medicine Market report are Tricyclic Antidepressants, Serotonin-norepinephrine Inhibitors, Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors, Benzodiazepines, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitors, Others

Recommended Reports

CNS Therapeutics

Pharmaceutical Market

Diagnostics & Specialty Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Depression Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tricyclic Antidepressants

1.2.3 Serotonin-norepinephrine Inhibitors

1.2.4 Atypical Antipsychotics

1.2.5 Selective Serotonin Reuptake Inhibitors

1.2.6 Benzodiazepines

1.2.7 Tetracyclic Antidepressants

1.2.8 Monoamine Oxidase Inhibitors

1.2.9 Others

1.3 Market by Application

1.3.1 Global Depression Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Depression Medicine Market Perspective (2020-2031)

2.2 Global Depression Medicine Growth Trends by Region

2.2.1 Global Depression Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Depression Medicine Historic Market Size by Region (2020-2025)

2.2.3 Depression Medicine Forecasted Market Size by Region (2026-2031)

2.3 Depression Medicine Market Dynamics

2.3.1 Depression Medicine Industry Trends

2.3.2 Depression Medicine Market Drivers

2.3.3 Depression Medicine Market Challenges

2.3.4 Depression Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Depression Medicine Players by Revenue

3.1.1 Global Top Depression Medicine Players by Revenue (2020-2025)

3.1.2 Global Depression Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Depression Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Depression Medicine Revenue

3.4 Global Depression Medicine Market Concentration Ratio

3.4.1 Global Depression Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Depression Medicine Revenue in 2024

3.5 Global Key Players of Depression Medicine Head office and Area Served

3.6 Global Key Players of Depression Medicine, Product and Application

3.7 Global Key Players of Depression Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Depression Medicine Breakdown Data by Type

4.1 Global Depression Medicine Historic Market Size by Type (2020-2025)

4.2 Global Depression Medicine Forecasted Market Size by Type (2026-2031)

5 Depression Medicine Breakdown Data by Application

5.1 Global Depression Medicine Historic Market Size by Application (2020-2025)

5.2 Global Depression Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Depression Medicine Market Size (2020-2031)

6.2 North America Depression Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Depression Medicine Market Size by Country (2020-2025)

6.4 North America Depression Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Depression Medicine Market Size (2020-2031)

7.2 Europe Depression Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Depression Medicine Market Size by Country (2020-2025)

7.4 Europe Depression Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Depression Medicine Market Size (2020-2031)

8.2 Asia-Pacific Depression Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Depression Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Depression Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Depression Medicine Market Size (2020-2031)

9.2 Latin America Depression Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Depression Medicine Market Size by Country (2020-2025)

9.4 Latin America Depression Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Depression Medicine Market Size (2020-2031)

10.2 Middle East & Africa Depression Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Depression Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Depression Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Depression Medicine Introduction

11.1.4 Pfizer Revenue in Depression Medicine Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Depression Medicine Introduction

11.2.4 AstraZeneca Revenue in Depression Medicine Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Details

11.3.2 Eli Lilly and Company Business Overview

11.3.3 Eli Lilly and Company Depression Medicine Introduction

11.3.4 Eli Lilly and Company Revenue in Depression Medicine Business (2020-2025)

11.3.5 Eli Lilly and Company Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Depression Medicine Introduction

11.4.4 Novartis Revenue in Depression Medicine Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Depression Medicine Introduction

11.5.4 GlaxoSmithKline Revenue in Depression Medicine Business (2020-2025)

11.5.5 GlaxoSmithKline Recent Development

11.6 Otsuka Pharmaceutical

11.6.1 Otsuka Pharmaceutical Company Details

11.6.2 Otsuka Pharmaceutical Business Overview

11.6.3 Otsuka Pharmaceutical Depression Medicine Introduction

11.6.4 Otsuka Pharmaceutical Revenue in Depression Medicine Business (2020-2025)

11.6.5 Otsuka Pharmaceutical Recent Development

11.7 Abbott Laboratories

11.7.1 Abbott Laboratories Company Details

11.7.2 Abbott Laboratories Business Overview

11.7.3 Abbott Laboratories Depression Medicine Introduction

11.7.4 Abbott Laboratories Revenue in Depression Medicine Business (2020-2025)

11.7.5 Abbott Laboratories Recent Development

11.8 Gedeon Richter

11.8.1 Gedeon Richter Company Details

11.8.2 Gedeon Richter Business Overview

11.8.3 Gedeon Richter Depression Medicine Introduction

11.8.4 Gedeon Richter Revenue in Depression Medicine Business (2020-2025)

11.8.5 Gedeon Richter Recent Development

11.9 Janssen Pharmaceuticals

11.9.1 Janssen Pharmaceuticals Company Details

11.9.2 Janssen Pharmaceuticals Business Overview

11.9.3 Janssen Pharmaceuticals Depression Medicine Introduction

11.9.4 Janssen Pharmaceuticals Revenue in Depression Medicine Business (2020-2025)

11.9.5 Janssen Pharmaceuticals Recent Development

11.10 Lupin Pharmaceuticals

11.10.1 Lupin Pharmaceuticals Company Details

11.10.2 Lupin Pharmaceuticals Business Overview

11.10.3 Lupin Pharmaceuticals Depression Medicine Introduction

11.10.4 Lupin Pharmaceuticals Revenue in Depression Medicine Business (2020-2025)

11.10.5 Lupin Pharmaceuticals Recent Development

11.11 Luye Pharma

11.11.1 Luye Pharma Company Details

11.11.2 Luye Pharma Business Overview

11.11.3 Luye Pharma Depression Medicine Introduction

11.11.4 Luye Pharma Revenue in Depression Medicine Business (2020-2025)

11.11.5 Luye Pharma Recent Development

11.12 MSI Methylation Sciences

11.12.1 MSI Methylation Sciences Company Details

11.12.2 MSI Methylation Sciences Business Overview

11.12.3 MSI Methylation Sciences Depression Medicine Introduction

11.12.4 MSI Methylation Sciences Revenue in Depression Medicine Business (2020-2025)

11.12.5 MSI Methylation Sciences Recent Development

11.13 Naurex

11.13.1 Naurex Company Details

11.13.2 Naurex Business Overview

11.13.3 Naurex Depression Medicine Introduction

11.13.4 Naurex Revenue in Depression Medicine Business (2020-2025)

11.13.5 Naurex Recent Development

11.14 SK Biopharmaceuticals

11.14.1 SK Biopharmaceuticals Company Details

11.14.2 SK Biopharmaceuticals Business Overview

11.14.3 SK Biopharmaceuticals Depression Medicine Introduction

11.14.4 SK Biopharmaceuticals Revenue in Depression Medicine Business (2020-2025)

11.14.5 SK Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Astrazeneca plc

Eli Lilly and Company

Novartis

GlaxoSmithKline PLC

Otsuka Pharmaceutical

Abbott Laboratories

Gedeon Richter

Janssen Pharmaceuticals

Lupin Pharmaceuticals

Luye Pharma

MSI Methylation Sciences

Naurex

SK Biopharmaceuticals

List of Tables

Table 1. Global Depression Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tricyclic Antidepressants

Table 3. Key Players of Serotonin-norepinephrine Inhibitors

Table 4. Key Players of Atypical Antipsychotics

Table 5. Key Players of Selective Serotonin Reuptake Inhibitors

Table 6. Key Players of Benzodiazepines

Table 7. Key Players of Tetracyclic Antidepressants

Table 8. Key Players of Monoamine Oxidase Inhibitors

Table 9. Global Depression Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Depression Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Depression Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Depression Medicine Market Share by Region (2020-2025)

Table 13. Global Depression Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Depression Medicine Market Share by Region (2026-2031)

Table 15. Depression Medicine Market Trends

Table 16. Depression Medicine Market Drivers

Table 17. Depression Medicine Market Challenges

Table 18. Depression Medicine Market Restraints

Table 19. Global Depression Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Depression Medicine Market Share by Players (2020-2025)

Table 21. Global Top Depression Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Medicine as of 2024)

Table 22. Ranking of Global Top Depression Medicine Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Depression Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Depression Medicine, Headquarters and Area Served

Table 25. Global Key Players of Depression Medicine, Product and Application

Table 26. Global Key Players of Depression Medicine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Depression Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Depression Medicine Revenue Market Share by Type (2020-2025)

Table 30. Global Depression Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Depression Medicine Revenue Market Share by Type (2026-2031)

Table 32. Global Depression Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Depression Medicine Revenue Market Share by Application (2020-2025)

Table 34. Global Depression Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Depression Medicine Revenue Market Share by Application (2026-2031)

Table 36. North America Depression Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Depression Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Depression Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Depression Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Depression Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Depression Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Depression Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Depression Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Depression Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Depression Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Depression Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Depression Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Depression Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Depression Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Depression Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Depression Medicine Product

Table 54. Pfizer Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Depression Medicine Product

Table 59. AstraZeneca Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Eli Lilly and Company Company Details

Table 62. Eli Lilly and Company Business Overview

Table 63. Eli Lilly and Company Depression Medicine Product

Table 64. Eli Lilly and Company Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 65. Eli Lilly and Company Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Depression Medicine Product

Table 69. Novartis Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. GlaxoSmithKline Company Details

Table 72. GlaxoSmithKline Business Overview

Table 73. GlaxoSmithKline Depression Medicine Product

Table 74. GlaxoSmithKline Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 75. GlaxoSmithKline Recent Development

Table 76. Otsuka Pharmaceutical Company Details

Table 77. Otsuka Pharmaceutical Business Overview

Table 78. Otsuka Pharmaceutical Depression Medicine Product

Table 79. Otsuka Pharmaceutical Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 80. Otsuka Pharmaceutical Recent Development

Table 81. Abbott Laboratories Company Details

Table 82. Abbott Laboratories Business Overview

Table 83. Abbott Laboratories Depression Medicine Product

Table 84. Abbott Laboratories Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 85. Abbott Laboratories Recent Development

Table 86. Gedeon Richter Company Details

Table 87. Gedeon Richter Business Overview

Table 88. Gedeon Richter Depression Medicine Product

Table 89. Gedeon Richter Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 90. Gedeon Richter Recent Development

Table 91. Janssen Pharmaceuticals Company Details

Table 92. Janssen Pharmaceuticals Business Overview

Table 93. Janssen Pharmaceuticals Depression Medicine Product

Table 94. Janssen Pharmaceuticals Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 95. Janssen Pharmaceuticals Recent Development

Table 96. Lupin Pharmaceuticals Company Details

Table 97. Lupin Pharmaceuticals Business Overview

Table 98. Lupin Pharmaceuticals Depression Medicine Product

Table 99. Lupin Pharmaceuticals Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 100. Lupin Pharmaceuticals Recent Development

Table 101. Luye Pharma Company Details

Table 102. Luye Pharma Business Overview

Table 103. Luye Pharma Depression Medicine Product

Table 104. Luye Pharma Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 105. Luye Pharma Recent Development

Table 106. MSI Methylation Sciences Company Details

Table 107. MSI Methylation Sciences Business Overview

Table 108. MSI Methylation Sciences Depression Medicine Product

Table 109. MSI Methylation Sciences Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 110. MSI Methylation Sciences Recent Development

Table 111. Naurex Company Details

Table 112. Naurex Business Overview

Table 113. Naurex Depression Medicine Product

Table 114. Naurex Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 115. Naurex Recent Development

Table 116. SK Biopharmaceuticals Company Details

Table 117. SK Biopharmaceuticals Business Overview

Table 118. SK Biopharmaceuticals Depression Medicine Product

Table 119. SK Biopharmaceuticals Revenue in Depression Medicine Business (2020-2025) & (US$ Million)

Table 120. SK Biopharmaceuticals Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Depression Medicine Picture

Figure 2. Global Depression Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Depression Medicine Market Share by Type: 2024 VS 2031

Figure 4. Tricyclic Antidepressants Features

Figure 5. Serotonin-norepinephrine Inhibitors Features

Figure 6. Atypical Antipsychotics Features

Figure 7. Selective Serotonin Reuptake Inhibitors Features

Figure 8. Benzodiazepines Features

Figure 9. Tetracyclic Antidepressants Features

Figure 10. Monoamine Oxidase Inhibitors Features

Figure 11. Others Features

Figure 12. Global Depression Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Depression Medicine Market Share by Application: 2024 VS 2031

Figure 14. Hospitals Case Studies

Figure 15. Clinics Case Studies

Figure 16. Others Case Studies

Figure 17. Depression Medicine Report Years Considered

Figure 18. Global Depression Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Depression Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Depression Medicine Market Share by Region: 2024 VS 2031

Figure 21. Global Depression Medicine Market Share by Players in 2024

Figure 22. Global Top Depression Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Medicine as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Depression Medicine Revenue in 2024

Figure 24. North America Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Depression Medicine Market Share by Country (2020-2031)

Figure 26. United States Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Depression Medicine Market Share by Country (2020-2031)

Figure 30. Germany Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Depression Medicine Market Share by Region (2020-2031)

Figure 38. China Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Depression Medicine Market Share by Country (2020-2031)

Figure 46. Mexico Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Depression Medicine Market Share by Country (2020-2031)

Figure 50. Turkey Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Depression Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Pfizer Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 55. Eli Lilly and Company Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 57. GlaxoSmithKline Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 58. Otsuka Pharmaceutical Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 59. Abbott Laboratories Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 60. Gedeon Richter Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 61. Janssen Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 62. Lupin Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 63. Luye Pharma Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 64. MSI Methylation Sciences Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 65. Naurex Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 66. SK Biopharmaceuticals Revenue Growth Rate in Depression Medicine Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Major Depressive Disorder Drug Market Research Report 2025

Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Free Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anxiety and Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antidepressant Medication Market Research Report 2025

Anxiety Disorders And Depression Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Insomnia Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Suicide Drug Market Research Report 2024

Psychiatric API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Pharmacological Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions